X-group (possible homology)

1114 Serine acetyltransferase N-terminal domain

Ligands and drugs

140
Member domains
76
with ligand contacts (≤ 4 Å)
54.3% of members
71
with DrugDomain annotations
50.7% of members
58
with a DrugBank compound
41.4% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

11
Proteins with classified ligands
4
Superclasses bound (of 23)
—
Superclasses per 20 proteins
fewer than 20 proteins: too few to compare at equal depth

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Homogeneous metal compounds25.30.38×q = 0.10
Organic acids and derivatives91.75.36×not tested
Organic oxygen compounds22.20.93×not tested
Homogeneous non-metal compounds22.30.86×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00151CYSCysteine37
DB00133SERSerine4
DB00125ARGArginine3
DB02078PG5Triglyme1

Most frequently bound compounds

PDB ligandNameDomains in contact
CYSCYSTEINE45
MGmetalMAGNESIUM ION13
NAmetalSODIUM ION7
SERSERINE5
LMR(2S)-2-hydroxybutanedioic acid4
ARGARGININE3
15PPOLYETHYLENE GLYCOL (N=34)2
CLCHLORIDE ION2
PG51-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE1